NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free LFST Stock Alerts $6.66 +0.13 (+1.99%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$6.47▼$6.7850-Day Range$5.62▼$8.7152-Week Range$4.74▼$9.59Volume1.33 million shsAverage Volume1.28 million shsMarket Capitalization$2.55 billionP/E RatioN/ADividend YieldN/APrice Target$8.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get LifeStance Health Group alerts: Email Address LifeStance Health Group MarketRank™ Stock AnalysisAnalyst RatingHold2.17 Rating ScoreUpside/Downside32.6% Upside$8.83 Price TargetShort InterestBearish21.73% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.12Based on 5 Articles This WeekInsider TradingSelling Shares$1.79 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.30) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.82 out of 5 starsMedical Sector3685th out of 5,430 stocksHealth Services Industry31st out of 60 stocks 3.1 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 2 buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 4 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted21.73% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 13.8, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 7.67%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 2.3 News and Social Media Coverage News SentimentLifeStance Health Group has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for LifeStance Health Group this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.MarketBeat Follows2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,786,868.00 in company stock.Percentage Held by InsidersOnly 8.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.30) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -13.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -13.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About LifeStance Health Group Stock (NASDAQ:LFST)LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Read More LFST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Stock News HeadlinesApril 20, 2024 | insidertrades.comInsider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells 12,965 Shares of StockApril 12, 2024 | insidertrades.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Paula Cipollone Sells 3,369 SharesMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)May 2, 2024 | americanbankingnews.comLifeStance Health Group (LFST) Set to Announce Earnings on ThursdayMay 1, 2024 | prnewswire.comLifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica AmbassadorsApril 30, 2024 | markets.businessinsider.comLifeist Announces Common Share ConsolidationApril 28, 2024 | nasdaq.comCommit To Purchase LifeStance Health Group At $4, Earn 13.7% Annualized Using OptionsApril 27, 2024 | nasdaq.comLifeStance Health Group, Inc. Common Stock (LFST)May 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 25, 2024 | americanbankingnews.comAnalysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Target Price at $8.60April 20, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (LFST)April 18, 2024 | globenewswire.comLifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024April 12, 2024 | finance.yahoo.comAt US$6.13, Is It Time To Put LifeStance Health Group, Inc. (NASDAQ:LFST) On Your Watch List?April 2, 2024 | benzinga.comLifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness BusinessApril 2, 2024 | markets.businessinsider.comLifeist Reports Fourth Quarter 2023 Financial ResultsMarch 20, 2024 | investing.comLifeStance Health executive sells over $280k in company stockMarch 20, 2024 | markets.businessinsider.comLifeist Announces Results of Annual General and Special Meeting of ShareholdersMarch 13, 2024 | investing.comLifestance Health Group Inc (LFST)March 12, 2024 | finance.yahoo.comLifeStance Appoints Dr. Teresa DeLuca to Board of DirectorsMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 2, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported And Analysts Have Been Lifting Their Price TargetsMarch 1, 2024 | seekingalpha.comLifeStance Health Group, Inc. (LFST) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comLifeStance Health Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 1, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)February 29, 2024 | ca.finance.yahoo.comLFST Oct 2024 3.000 putFebruary 29, 2024 | markets.businessinsider.comBarclays Keeps Their Sell Rating on Lifestance Health Group (LFST)See More Headlines Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today5/04/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees9,325Year FoundedN/APrice Target and Rating Average Stock Price Target$8.83 High Stock Price Target$10.00 Low Stock Price Target$8.00 Potential Upside/Downside+32.6%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-186,260,000.00 Net Margins-17.64% Pretax Margin-19.57% Return on Equity-12.66% Return on Assets-8.65% Debt Debt-to-Equity Ratio0.20 Current Ratio1.11 Quick Ratio1.11 Sales & Book Value Annual Sales$1.06 billion Price / Sales2.41 Cash FlowN/A Price / Cash FlowN/A Book Value$3.77 per share Price / Book1.77Miscellaneous Outstanding Shares382,240,000Free Float349,749,000Market Cap$2.55 billion OptionableOptionable Beta1.29 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Kenneth Alan Burdick (Age 65)CEO & Chairman Comp: $624.22kMr. Danish J. Qureshi (Age 39)President & COO Comp: $342.2kMr. David Patrick Bourdon (Age 54)Chief Financial Officer & Treasurer Comp: $368.6kMs. Monica ProkockiVice President of Investor RelationsMr. Ryan Pardo (Age 48)Chief Legal Officer & Secretary Brooke MatthewsDirector of Public RelationsMs. Ann Varanakis (Age 46)Chief People Officer Mr. Pablo Pantaleoni (Age 36)Chief Digital Officer Mr. Kevin Michael Mullins (Age 39)Chief Development Officer Ms. Paula WoodChief Business Transformation OfficerMore ExecutivesKey CompetitorsApollo MedicalNASDAQ:AMEHMagellan HealthNASDAQ:MGLNPrivia Health GroupNASDAQ:PRVAProgynyNASDAQ:PGNY1Life HealthcareNASDAQ:ONEMView All CompetitorsInsiders & InstitutionsGSA Capital Partners LLPBought 42,932 shares on 5/3/2024Ownership: 0.018%Jennison Associates LLCBought 12,629 shares on 5/2/2024Ownership: 0.507%Mirae Asset Global Investments Co. Ltd.Bought 27,605 shares on 5/1/2024Ownership: 0.048%Caprock Group LLCSold 58,473 shares on 4/30/2024Ownership: 0.003%Principal Financial Group Inc.Sold 45,393 shares on 4/29/2024Ownership: 1.036%View All Insider TransactionsView All Institutional Transactions LFST Stock Analysis - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LFST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFST, but not buy additional shares or sell existing shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price target for 2024? 6 brokers have issued twelve-month price objectives for LifeStance Health Group's stock. Their LFST share price targets range from $8.00 to $10.00. On average, they predict the company's share price to reach $8.83 in the next year. This suggests a possible upside of 32.6% from the stock's current price. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2024? LifeStance Health Group's stock was trading at $7.83 on January 1st, 2024. Since then, LFST stock has decreased by 14.9% and is now trading at $6.66. View the best growth stocks for 2024 here. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our LFST earnings forecast. How can I listen to LifeStance Health Group's earnings call? LifeStance Health Group will be holding an earnings conference call on Thursday, May 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) announced its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.03. The firm earned $280.60 million during the quarter, compared to the consensus estimate of $263.14 million. LifeStance Health Group had a negative trailing twelve-month return on equity of 12.66% and a negative net margin of 17.64%. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), SPDR S&P Health Care Services ETF (XHS) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $287.0 million-$307.0 million, compared to the consensus revenue estimate of $299.1 million. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Principal Financial Group Inc. (1.04%), Jennison Associates LLC (0.51%), O Brien Wealth Partners LLC (0.14%), Mirae Asset Global Investments Co. Ltd. (0.05%), GSA Capital Partners LLP (0.02%) and Caprock Group LLC (0.00%). Insiders that own company stock include Anisha Patel-Dunn, Ann Varanakis, Danish J Qureshi, David Bourdon, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Paula Cipollone, Ryan Pardo, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LFST) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.